EFFECTIVENESS AND SAFETY OF TOCILIZUMAB IN BIOLOGICS NAIVE RA PATIENTS - PMS FOR INVESTIGATING SUCCESS IN ACHIEVING CLINICAL AND FUNCTIONAL REMISSION AND SUSTAINING EFFICACY WITH TOCILIZUMAB IN BIOLOGICS-NAIVE RA PATIENTS (FIRST BIO) STUDY

被引：0
|
作者：
Mimori, T. [1 ]
Atsumi, T. [2 ]
Harigai, M. [3 ]
Nishimoto, N. [4 ]
Sumida, T. [5 ]
Takeuchi, T. [6 ]
Tanaka, Y. [7 ]
Yamanaka, H. [8 ]
Nakasone, A. [9 ]
Takagi, N. [9 ]
Ishiguro, N. [10 ]
机构：
[1] Kyoto Univ, Kyoto, Japan
[2] Hokkaido Univ, Sapporo, Hokkaido, Japan
[3] Tokyo Med & Dent Univ, Tokyo, Japan
[4] Tokyo Med Univ, Tokyo, Japan
[5] Univ Tsukuba, Tsukuba, Ibaraki, Japan
[6] Keio Univ, Tokyo, Japan
[7] Univ Occupat & Environm Hlth, Kitakyushu, Fukuoka, Japan
[8] Tokyo Womens Med Univ, Inst Rheumatol, Tokyo, Japan
[9] Chugai Pharmaceut, Tokyo, Japan
[10] Nagoya Univ Hosp, Nagoya, Aichi, Japan
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.1829
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0211
引用
收藏
页码：733 / 733
页数：1
相关论文
共 17 条
  • [1] Effectiveness and Safety of Tocilizumab in Biologics-Naive RA Patients-Postmarketing Surveillance for Investigating Success in Achieving Clinical and Functional Remission and Sustaining Efficacy with Tocilizumab in Biologics-Naive RA Patients (FIRST Bio) Study
    Ishiguro, Naoki
    Atsumi, Tatsuya
    Harigai, Masayoshi
    Mimori, Tsuneyo
    Nishimoto, Norihiro
    Sumida, Takayuki
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Takagi, Nobuhiro
    Nakasone, Ayako
    Yamanaka, Hisashi
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [2] Effectiveness and Safety of Tocilizumab in Biologics Naive RA Patients - Interim Analysis of PMS for Investigating Success in Achieving Clinical and Functional Remission and Sustaining Efficacy with Tocilizumab in Biologics-Naive RA Patients Study.
    Ishiguro, Naoki
    Atsumi, Tatsuya
    Harigai, Masayoshi
    Mimori, Tsuneyo
    Nishimoto, Norihiro
    Sumida, Takayuki
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Takagi, Nobuhiro
    Tanaka, Kunihiko
    Yamanaka, Hisashi
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S1075 - S1076
  • [3] Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study
    Ishiguro, Naoki
    Atsumi, Tatsuya
    Harigai, Masayoshi
    Mimori, Tsuneyo
    Nishimoto, Norihiro
    Sumida, Takayuki
    Takeuchi, Tsutomu
    Tanaka, Yoshiya
    Nakasone, Ayako
    Takagi, Nobuhiro
    Yamanaka, Hisashi
    MODERN RHEUMATOLOGY, 2017, 27 (02) : 217 - 226
  • [4] EFFECT OF BASELINE DISEASE DURATION ON DEVELOPMENT OF CLINICAL REMISSION IN THE RA PATIENTS RECEIVING TOCILIZUMAB - DATA FROM PMS WITH TOCILIZUMAB IN BIOLOGICS-NAIVE RA PATIENTS (FIRST BIO) STUDY
    Mimori, T.
    Atsumi, T.
    Harigai, M.
    Nishimoto, N.
    Sumida, T.
    Takeuchi, T.
    Tanaka, Y.
    Yamanaka, H.
    Nakasone, A.
    Takagi, N.
    Ishiguro, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1060 - 1060
  • [5] Do biologics-naive patients with rheumatoid arthritis respond better to tocilizumab than patients for whom anti-TNF agents have failed? A retrospective study
    Wakabayashi, H.
    Oka, H.
    Nishioka, Y.
    Hasegawa, M.
    Sudo, A.
    Nishioka, K.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 314 - 317
  • [6] Effectiveness of Combination Therapy with Tocilizumab and Low-Dose Prednisolone as an Induction Therapy in Biologics-Naive Patients with Rheumatoid Arthritis: A Prospective, Randomized, Controlled, Open-Label, Multicenter Study
    Yokota, Kazuhiro
    Nagasawa, Hayato
    Akiyama, Yuji
    Mimura, Toshihide
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 2830 - 2831
  • [7] Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
    Sakai, Ryoko
    Cho, Soo-Kyung
    Nanki, Toshihiro
    Watanabe, Kaori
    Yamazaki, Hayato
    Tanaka, Michi
    Koike, Ryuji
    Tanaka, Yoshiya
    Saito, Kazuyoshi
    Hirata, Shintaro
    Amano, Koichi
    Nagasawa, Hayato
    Sumida, Takayuki
    Hayashi, Taichi
    Sugihara, Takahiko
    Dobashi, Hiroaki
    Yasuda, Shinsuke
    Sawada, Tetsuji
    Ezawa, Kazuhiko
    Ueda, Atsuhisa
    Fujii, Takao
    Migita, Kiyoshi
    Miyasaka, Nobuyuki
    Harigai, Masayoshi
    ARTHRITIS RESEARCH & THERAPY, 2015, 17
  • [8] Head-to-head comparison of the safety of tocilizumab and tumor necrosis factor inhibitors in rheumatoid arthritis patients (RA) in clinical practice: results from the registry of Japanese RA patients on biologics for long-term safety (REAL) registry
    Ryoko Sakai
    Soo-Kyung Cho
    Toshihiro Nanki
    Kaori Watanabe
    Hayato Yamazaki
    Michi Tanaka
    Ryuji Koike
    Yoshiya Tanaka
    Kazuyoshi Saito
    Shintaro Hirata
    Koichi Amano
    Hayato Nagasawa
    Takayuki Sumida
    Taichi Hayashi
    Takahiko Sugihara
    Hiroaki Dobashi
    Shinsuke Yasuda
    Tetsuji Sawada
    Kazuhiko Ezawa
    Atsuhisa Ueda
    Takao Fujii
    Kiyoshi Migita
    Nobuyuki Miyasaka
    Masayoshi Harigai
    Arthritis Research & Therapy, 17
  • [9] BASELINE OSTEOPONTIN LEVELS PREDICT THE CLINICAL EFFICACY OF TOCILIZUMAB NOT INFLIXIMAB IN BIO-NAIVE RHEUMATOID ARTHRITIS PATIENTS: THE KEIO FIRST BIO COHORT AT 1 YEAR
    Izumi, K.
    Kaneko, Y.
    Hashizume, M.
    Nishina, N.
    Kikuchi, J.
    Yoshimoto, K.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 384 - 384
  • [10] WEIGHTED GENE CO-EXPRESSION NETWORK ANALYSIS OF DMARD-NAIVE EARLY RA PATIENTS ACHIEVING SUSTAINED DRUG-FREE REMISSION AFTER INITIATING TOCILIZUMAB THERAPY
    Teitsma, X. M.
    Jacobs, J. W.
    Mokry, M.
    Petho-Schramm, A.
    Borm, M. E.
    van Laar, J. M.
    Bijlsma, J. W.
    Lafeber, F. P.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 177 - 178
12